1 Oral Anti-Diabetic Drug Market Overview 1.1 Product Overview and Scope of Oral Anti-Diabetic Drug 1.2 Oral Anti-Diabetic Drug Segment by Type 1.2.1 Global Oral Anti-Diabetic Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Glimepiride 1.2.3 Gliclazide 1.2.4 Glyburide 1.2.5 Others 1.3 Oral Anti-Diabetic Drug Segment by Application 1.3.1 Oral Anti-Diabetic Drug Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Research Institual 1.4 Global Oral Anti-Diabetic Drug Market Size Estimates and Forecasts 1.4.1 Global Oral Anti-Diabetic Drug Revenue 2016-2027 1.4.2 Global Oral Anti-Diabetic Drug Sales 2016-2027 1.4.3 Oral Anti-Diabetic Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Oral Anti-Diabetic Drug Market Competition by Manufacturers 2.1 Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Oral Anti-Diabetic Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Oral Anti-Diabetic Drug Manufacturing Sites, Area Served, Product Type 2.5 Oral Anti-Diabetic Drug Market Competitive Situation and Trends 2.5.1 Oral Anti-Diabetic Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Oral Anti-Diabetic Drug Players Market Share by Revenue 2.5.3 Global Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Oral Anti-Diabetic Drug Retrospective Market Scenario by Region 3.1 Global Oral Anti-Diabetic Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Oral Anti-Diabetic Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Oral Anti-Diabetic Drug Market Facts & Figures by Country 3.3.1 North America Oral Anti-Diabetic Drug Sales by Country 3.3.2 North America Oral Anti-Diabetic Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Oral Anti-Diabetic Drug Market Facts & Figures by Country 3.4.1 Europe Oral Anti-Diabetic Drug Sales by Country 3.4.2 Europe Oral Anti-Diabetic Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Oral Anti-Diabetic Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Oral Anti-Diabetic Drug Sales by Region 3.5.2 Asia Pacific Oral Anti-Diabetic Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Oral Anti-Diabetic Drug Market Facts & Figures by Country 3.6.1 Latin America Oral Anti-Diabetic Drug Sales by Country 3.6.2 Latin America Oral Anti-Diabetic Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Oral Anti-Diabetic Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Oral Anti-Diabetic Drug Sales by Country 3.7.2 Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Oral Anti-Diabetic Drug Historic Market Analysis by Type 4.1 Global Oral Anti-Diabetic Drug Sales Market Share by Type (2016-2021) 4.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2016-2021) 4.3 Global Oral Anti-Diabetic Drug Price by Type (2016-2021) 5 Global Oral Anti-Diabetic Drug Historic Market Analysis by Application 5.1 Global Oral Anti-Diabetic Drug Sales Market Share by Application (2016-2021) 5.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2016-2021) 5.3 Global Oral Anti-Diabetic Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Takeda 6.1.1 Takeda Corporation Information 6.1.2 Takeda Description and Business Overview 6.1.3 Takeda Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Takeda Product Portfolio 6.1.5 Takeda Recent Developments/Updates 6.2 Pfizer 6.2.1 Pfizer Corporation Information 6.2.2 Pfizer Description and Business Overview 6.2.3 Pfizer Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Pfizer Product Portfolio 6.2.5 Pfizer Recent Developments/Updates 6.3 Eli Lilly 6.3.1 Eli Lilly Corporation Information 6.3.2 Eli Lilly Description and Business Overview 6.3.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Eli Lilly Product Portfolio 6.3.5 Eli Lilly Recent Developments/Updates 6.4 Janssen Pharmaceuticals 6.4.1 Janssen Pharmaceuticals Corporation Information 6.4.2 Janssen Pharmaceuticals Description and Business Overview 6.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Janssen Pharmaceuticals Product Portfolio 6.4.5 Janssen Pharmaceuticals Recent Developments/Updates 6.5 Astellas 6.5.1 Astellas Corporation Information 6.5.2 Astellas Description and Business Overview 6.5.3 Astellas Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Astellas Product Portfolio 6.5.5 Astellas Recent Developments/Updates 6.6 Boehringer Ingelheim 6.6.1 Boehringer Ingelheim Corporation Information 6.6.2 Boehringer Ingelheim Description and Business Overview 6.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Boehringer Ingelheim Product Portfolio 6.6.5 Boehringer Ingelheim Recent Developments/Updates 6.7 Merck And Co. 6.6.1 Merck And Co. Corporation Information 6.6.2 Merck And Co. Description and Business Overview 6.6.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Merck And Co. Product Portfolio 6.7.5 Merck And Co. Recent Developments/Updates 6.8 AstraZeneca 6.8.1 AstraZeneca Corporation Information 6.8.2 AstraZeneca Description and Business Overview 6.8.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.8.4 AstraZeneca Product Portfolio 6.8.5 AstraZeneca Recent Developments/Updates 6.9 Bristol Myers Squibb 6.9.1 Bristol Myers Squibb Corporation Information 6.9.2 Bristol Myers Squibb Description and Business Overview 6.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Bristol Myers Squibb Product Portfolio 6.9.5 Bristol Myers Squibb Recent Developments/Updates 6.10 Novartis 6.10.1 Novartis Corporation Information 6.10.2 Novartis Description and Business Overview 6.10.3 Novartis Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Novartis Product Portfolio 6.10.5 Novartis Recent Developments/Updates 6.11 Sanofi 6.11.1 Sanofi Corporation Information 6.11.2 Sanofi Oral Anti-Diabetic Drug Description and Business Overview 6.11.3 Sanofi Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Sanofi Product Portfolio 6.11.5 Sanofi Recent Developments/Updates 6.12 Abbott 6.12.1 Abbott Corporation Information 6.12.2 Abbott Oral Anti-Diabetic Drug Description and Business Overview 6.12.3 Abbott Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Abbott Product Portfolio 6.12.5 Abbott Recent Developments/Updates 6.13 Biocon 6.13.1 Biocon Corporation Information 6.13.2 Biocon Oral Anti-Diabetic Drug Description and Business Overview 6.13.3 Biocon Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Biocon Product Portfolio 6.13.5 Biocon Recent Developments/Updates 7 Oral Anti-Diabetic Drug Manufacturing Cost Analysis 7.1 Oral Anti-Diabetic Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Oral Anti-Diabetic Drug 7.4 Oral Anti-Diabetic Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Oral Anti-Diabetic Drug Distributors List 8.3 Oral Anti-Diabetic Drug Customers 9 Oral Anti-Diabetic Drug Market Dynamics 9.1 Oral Anti-Diabetic Drug Industry Trends 9.2 Oral Anti-Diabetic Drug Growth Drivers 9.3 Oral Anti-Diabetic Drug Market Challenges 9.4 Oral Anti-Diabetic Drug Market Restraints 10 Global Market Forecast 10.1 Oral Anti-Diabetic Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Oral Anti-Diabetic Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Oral Anti-Diabetic Drug by Type (2022-2027) 10.2 Oral Anti-Diabetic Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Oral Anti-Diabetic Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Oral Anti-Diabetic Drug by Application (2022-2027) 10.3 Oral Anti-Diabetic Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Oral Anti-Diabetic Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Oral Anti-Diabetic Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Oral Anti-Diabetic Drug Sales (K Tons) Growth Rate Comparison by Type (2021-2027) Table 2. Global Oral Anti-Diabetic Drug Sales (K Tons) Comparison by Application (2021-2027) Table 3. Global Oral Anti-Diabetic Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Oral Anti-Diabetic Drug Covered in This Study Table 5. Global Oral Anti-Diabetic Drug Sales (K Tons) of Key Manufacturers (2016-2021) Table 6. Global Oral Anti-Diabetic Drug Sales Share by Manufacturers (2016-2021) Table 7. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Oral Anti-Diabetic Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Oral Anti-Diabetic Drug Average Price (USD/Ton) of Key Manufacturers (2016-2021) Table 10. Manufacturers Oral Anti-Diabetic Drug Manufacturing Sites and Area Served Table 11. Manufacturers Oral Anti-Diabetic Drug Product Type Table 12. Global Oral Anti-Diabetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Oral Anti-Diabetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Anti-Diabetic Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Oral Anti-Diabetic Drug Sales by Region (2016-2021) & (K Tons) Table 16. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2016-2021) Table 17. Global Oral Anti-Diabetic Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Oral Anti-Diabetic Drug Sales by Country (2016-2021) & (K Tons) Table 19. North America Oral Anti-Diabetic Drug Sales Market Share by Country (2016-2021) Table 20. North America Oral Anti-Diabetic Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Oral Anti-Diabetic Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Oral Anti-Diabetic Drug Sales by Country (2016-2021) & (K Tons) Table 23. Europe Oral Anti-Diabetic Drug Sales Market Share by Country (2016-2021) Table 24. Europe Oral Anti-Diabetic Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Oral Anti-Diabetic Drug Sales by Region (2016-2021) & (K Tons) Table 27. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Oral Anti-Diabetic Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Oral Anti-Diabetic Drug Sales by Country (2016-2021) & (K Tons) Table 31. Latin America Oral Anti-Diabetic Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Oral Anti-Diabetic Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Oral Anti-Diabetic Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2016-2021) & (K Tons) Table 35. Middle East and Africa Oral Anti-Diabetic Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Oral Anti-Diabetic Drug Revenue Market Share by Country (2016-2021) Table 38. Global Oral Anti-Diabetic Drug Sales (K Tons) by Type (2016-2021) Table 39. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2016-2021) Table 40. Global Oral Anti-Diabetic Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Oral Anti-Diabetic Drug Revenue Share by Type (2016-2021) Table 42. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Type (2016-2021) Table 43. Global Oral Anti-Diabetic Drug Sales (K Tons) by Application (2016-2021) Table 44. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2016-2021) Table 45. Global Oral Anti-Diabetic Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Oral Anti-Diabetic Drug Revenue Share by Application (2016-2021) Table 47. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Application (2016-2021) Table 48. Takeda Corporation Information Table 49. Takeda Description and Business Overview Table 50. Takeda Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 51. Takeda Oral Anti-Diabetic Drug Product Table 52. Takeda Recent Developments/Updates Table 53. Pfizer Corporation Information Table 54. Pfizer Description and Business Overview Table 55. Pfizer Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 56. Pfizer Oral Anti-Diabetic Drug Product Table 57. Pfizer Recent Developments/Updates Table 58. Eli Lilly Corporation Information Table 59. Eli Lilly Description and Business Overview Table 60. Eli Lilly Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 61. Eli Lilly Oral Anti-Diabetic Drug Product Table 62. Eli Lilly Recent Developments/Updates Table 63. Janssen Pharmaceuticals Corporation Information Table 64. Janssen Pharmaceuticals Description and Business Overview Table 65. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 66. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Table 67. Janssen Pharmaceuticals Recent Developments/Updates Table 68. Astellas Corporation Information Table 69. Astellas Description and Business Overview Table 70. Astellas Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 71. Astellas Oral Anti-Diabetic Drug Product Table 72. Astellas Recent Developments/Updates Table 73. Boehringer Ingelheim Corporation Information Table 74. Boehringer Ingelheim Description and Business Overview Table 75. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 76. Boehringer Ingelheim Oral Anti-Diabetic Drug Product Table 77. Boehringer Ingelheim Recent Developments/Updates Table 78. Merck And Co. Corporation Information Table 79. Merck And Co. Description and Business Overview Table 80. Merck And Co. Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 81. Merck And Co. Oral Anti-Diabetic Drug Product Table 82. Merck And Co. Recent Developments/Updates Table 83. AstraZeneca Corporation Information Table 84. AstraZeneca Description and Business Overview Table 85. AstraZeneca Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 86. AstraZeneca Oral Anti-Diabetic Drug Product Table 87. AstraZeneca Recent Developments/Updates Table 88. Bristol Myers Squibb Corporation Information Table 89. Bristol Myers Squibb Description and Business Overview Table 90. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 91. Bristol Myers Squibb Oral Anti-Diabetic Drug Product Table 92. Bristol Myers Squibb Recent Developments/Updates Table 93. Novartis Corporation Information Table 94. Novartis Description and Business Overview Table 95. Novartis Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 96. Novartis Oral Anti-Diabetic Drug Product Table 97. Novartis Recent Developments/Updates Table 98. Sanofi Corporation Information Table 99. Sanofi Description and Business Overview Table 100. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 101. Sanofi Oral Anti-Diabetic Drug Product Table 102. Sanofi Recent Developments/Updates Table 103. Abbott Corporation Information Table 104. Abbott Description and Business Overview Table 105. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 106. Abbott Oral Anti-Diabetic Drug Product Table 107. Abbott Recent Developments/Updates Table 108. Biocon Corporation Information Table 109. Biocon Description and Business Overview Table 110. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2016-2021) Table 111. Biocon Oral Anti-Diabetic Drug Product Table 112. Biocon Recent Developments/Updates Table 113. Production Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Oral Anti-Diabetic Drug Distributors List Table 116. Oral Anti-Diabetic Drug Customers List Table 117. Oral Anti-Diabetic Drug Market Trends Table 118. Oral Anti-Diabetic Drug Growth Drivers Table 119. Oral Anti-Diabetic Drug Market Restraints Table 120. Global Oral Anti-Diabetic Drug Sales Forecast by Type (2022-2027) & (K Tons) Table 121. Global Oral Anti-Diabetic Drug Sales Market Share Forecast by Type (2022-2027) Table 122. Global Oral Anti-Diabetic Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 123. Global Oral Anti-Diabetic Drug Revenue Market Share Forecast by Type (2022-2027) Table 124. Global Oral Anti-Diabetic Drug Sales Forecast by Application (2022-2027) & (K Tons) Table 125. Global Oral Anti-Diabetic Drug Sales Market Share Forecast by Application (2022-2027) Table 126. Global Oral Anti-Diabetic Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 127. Global Oral Anti-Diabetic Drug Revenue Market Share Forecast by Application (2022-2027) Table 128. Global Oral Anti-Diabetic Drug Sales Forecast by Region (2022-2027) & (K Tons) Table 129. Global Oral Anti-Diabetic Drug Sales Market Share Forecast by Region (2022-2027) Table 130. Global Oral Anti-Diabetic Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 131. Global Oral Anti-Diabetic Drug Revenue Market Share Forecast by Region (2022-2027) Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Oral Anti-Diabetic Drug Figure 2. Global Oral Anti-Diabetic Drug Market Share by Type in 2020 & 2027 Figure 3. Glimepiride Product Picture Figure 4. Gliclazide Product Picture Figure 5. Glyburide Product Picture Figure 6. Others Product Picture Figure 7. Global Oral Anti-Diabetic Drug Market Share by Application in 2020 & 2027 Figure 8. Hospital Figure 9. Research Institual Figure 10. Global Oral Anti-Diabetic Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Oral Anti-Diabetic Drug Market Size 2016-2027 (US$ Million) Figure 12. Global Oral Anti-Diabetic Drug Sales 2016-2027 (K Tons) Figure 13. Global Oral Anti-Diabetic Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Oral Anti-Diabetic Drug Sales Share by Manufacturers in 2020 Figure 15. Global Oral Anti-Diabetic Drug Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Oral Anti-Diabetic Drug Players: Market Share by Revenue in 2020 Figure 17. Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2016-2021) Figure 19. Global Oral Anti-Diabetic Drug Sales Market Share by Region in 2020 Figure 20. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2016-2021) Figure 21. Global Oral Anti-Diabetic Drug Revenue Market Share by Region in 2020 Figure 22. U.S. Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Oral Anti-Diabetic Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Oral Anti-Diabetic Drug by Type (2016-2021) Figure 47. Sales Market Share of Oral Anti-Diabetic Drug by Application (2016-2021) Figure 48. Sales Market Share of Oral Anti-Diabetic Drug by Application in 2020 Figure 49. Revenue Share of Oral Anti-Diabetic Drug by Application (2016-2021) Figure 50. Revenue Share of Oral Anti-Diabetic Drug by Application in 2020 Figure 51. Manufacturing Cost Structure of Oral Anti-Diabetic Drug Figure 52. Manufacturing Process Analysis of Oral Anti-Diabetic Drug Figure 53. Oral Anti-Diabetic Drug Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Takeda Pfizer Eli Lilly Janssen Pharmaceuticals Astellas Boehringer Ingelheim Merck And Co. AstraZeneca Bristol Myers Squibb Novartis Sanofi Abbott Biocon